Hypervision Surgical has expanded its team with the appointment of Stuti Pant as Research Development Manager, strengthening the company’s focus on public investment and grant funding.
Stuti is an expert in securing grant funding from major national and international organisations, underpinned by a strong academic background in brain sciences. With over a decade of experience in clinical research programme management and fundraising, she has successfully secured competitive grants from bodies including the NIHR, NIH, MRC, and Horizon Europe, particularly within the clinical and global health sectors.
She joins Hypervision from Imperial College London, where she led multi-country and multi-centre research programmes from inception through design, development, and delivery. Her expertise in the public funding landscape and strategic understanding of grant mechanisms align strongly with Hypervision’s mission to leverage public investment to accelerate innovation in surgical safety and precision.
In her new role, Stuti will lead Hypervision’s public funding strategy, positioning the company to capitalise on non-dilutive funding opportunities while advancing the commercial development of its real-time hyperspectral imaging technology for the operating room.
I am delighted to join the team at Hypervision Surgical and to be part of a company dedicated to enhancing the safety and effectiveness of surgical procedures. It is inspiring to see the company’s journey and commitment to innovation in this field. I believe Hypervision’s technology holds groundbreaking potential, not only in colorectal surgery but across various surgical applications, and I am excited to contribute to the R&D strategy and ongoing advancements.
— Stuti Pant